Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences (Q39942163)

15 September 2017

Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences (English)

1 reference

15 September 2017

1

Björn Wettermark

1 reference

15 September 2017

Brian Godman

2

1 reference

PubMed ID

19799468

15 September 2017

Bengt Jacobsson

series ordinal

3

1 reference

PubMed ID

19799468

15 September 2017

Flora M Haaijer-Ruskamp

series ordinal

4

1 reference

15 September 2017

1 January 2009

1 reference

Applied Health Economics and Health Policy

15 September 2017

1 reference

15 September 2017

7

1 reference

15 September 2017

3

1 reference

15 September 2017

137-147

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256147

15 September 2017

0 references

cites work

Enhancing the rational use of new medicines across European health care systems

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Prevalence and treatment of diabetes in France: trends between 2000 and 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Health plans' strategies to control prescription drug spending

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

From best evidence to best practice: effective implementation of change in patients' care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Pharmacotherapeutic circles. Results of an 18-month peer-review prescribing-improvement programme for general practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Impact of quality circles for improvement of asthma care: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Insight into recent reforms and initiatives in Austria: implications for key stakeholders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

"Get smart Colorado": impact of a mass media campaign to improve community antibiotic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Criticism of new German chronic disease management is unfair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Pharmacists' interventions for optimization of medication use in nursing homes : a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Nurse and pharmacist supplementary prescribing in the UK--a thematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Prescribing new drugs: qualitative study of influences on consultants and general practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

The drug budget silo mentality: the French case

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

The last decade of Italian pharmaceutical policy: instability or consolidation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

21 January 2018

Using clinical evidence

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Effectiveness of quality improvement: learning from evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Doctors' education: the invisible influence of drug company sponsorship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Medical journals and pharmaceutical companies: uneasy bedfellows.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Fundholders' prescribing costs: the first five years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Effects of a behaviour independent financial incentive on prescribing behaviour of general practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Affordability of medicines and patients' cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Why do we need randomised controlled trials to assess behavioural interventions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Pay-for-performance programs in family practices in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Paying physicians for high-quality care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Public reporting in health care: how do consumers use quality-of-care information? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

New medicines in primary care: a review of influences on general practitioner prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

How much will Herceptin really cost?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Evidence of self-report bias in assessing adherence to guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Institutionalized Organizations: Formal Structure as Myth and Ceremony

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Overbilling vs. downcoding--the battle between physicians and insurers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Evaluating and researching the effectiveness of educational interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

How can we regulate medicines better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Research designs for studies evaluating the effectiveness of change and improvement strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

When Is It Cost-effective to Change the Behavior of Health Professionals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Prescribing Incentive Schemes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

Quality Incentives: The Case Of U.K. General Practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256147

21 January 2018

Identifiers

DOI

10.1007/BF03256147

1 reference

15 September 2017

1 reference

PubMed ID

19799468